Redcliffe Labs and the Rajiv Gandhi Centre for Biotechnology have partnered to manage a modern genomics laboratory in Thiruvananthapuram, using Single Cell Genomics and High-Throughput Sequencing technologies, with the aim of transforming India's genomics landscape through a memorandum of understanding.

RGCB's advanced genomics facility has enabled pioneering Single Cell genomics initiatives. This platform provides insights into functional genomics, analyzing samples from humans, plants, and microbes. It uses RNA and DNA-based applications and focuses on cellular biology, including cell stages, signaling, and lineages. This technology is expected to shape targeted therapies, precise drug dosages, and personalized medicine, paving the way for future advancements.

Redcliffe Labs has partnered with RGCB to introduce advanced technologies like 10X Chromium, Illumina Novaseq, and Nanopore Gridion, aiming to streamline sample analysis in the southern region of the country, with two fully equipped genomics facilities now in place.

Ashish Dubey, Director of Research, Redcliffe Labs said, “Our focused approach towards fastest and quality delivery has put us in the top three genomics service providers in the country and the 1st to have access to 2 full-fledged genomic labs. With the addition of this infrastructure, we are confident of delivering the projects and the clinical reports faster than before by reducing our sample transport time and logistics advantage.” We aim to provide efficient, cost-effective, and high throughput NGS services to Kerala’s Research centers like IISR, RCC, CIFE, IISER, NISER, CPCRI, and various PSUs. This facility will be a great support system for many genomics startups in Kerala, which is turning out to be a new home for Genomics startups after Karnataka and Telangana.”

Prof. Chandrabhas Narayana, Director, RGCB, Thiruvananthapuram said, “ At RGCB, our research is focused on understanding disease biology and processing this knowledge for better management and therapeutics. Genomics-based technologies like NGS help researchers and breeders evaluate and predict genetic merit. I am confident that partnering with Redcliffe’s genomics services will expedite our journey towards making discoveries for better life and life forms. This will serve as a catalyst in translating discoveries effectively to eventual implementation for public benefit.”